SSII
NASDAQ · Health Care
Ss Innovations International
$4.94
-0.07 (-1.40%)
Financial Highlights (FY 2026)
Revenue
8.12M
Net Income
-28,836,683
Gross Margin
12.3%
Profit Margin
-355.1%
Rev Growth
—
D/E Ratio
0.33
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 12.3% | 50.7% | 50.7% | 50.7% |
| Operating Margin | -344.8% | 15.8% | 14.1% | 14.1% |
| Profit Margin | -355.1% | 14.0% | 15.1% | 11.5% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 8.12M | 294.54M | 262.27M | 240.92M |
| Gross Profit | 1.00M | 149.45M | 133.07M | 122.24M |
| Operating Income | -28,014,778 | 46.64M | 37.10M | 34.03M |
| Net Income | -28,836,683 | 41.36M | 39.46M | 27.71M |
| Gross Margin | 12.3% | 50.7% | 50.7% | 50.7% |
| Operating Margin | -344.8% | 15.8% | 14.1% | 14.1% |
| Profit Margin | -355.1% | 14.0% | 15.1% | 11.5% |
| Rev Growth | — | +7.6% | +2.3% | +6.1% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 118.72M | 118.45M | 152.33M | 135.17M |
| Total Equity | 358.56M | 508.27M | 516.61M | 488.41M |
| D/E Ratio | 0.33 | 0.23 | 0.29 | 0.28 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | -27,796,081 | 48.96M | 47.08M | 43.40M |
| Free Cash Flow | — | 24.60M | 19.43M | 18.07M |